3

SEC Filing Details

Document Details

Form
Filing Date
Sep 12, 2017
Document Date
Sep 11, 2017
Form Description

Initial filing by director officer or owner of more than ten percent.

Filing Group
3,4,5
Company
Opiant Pharmaceuticals, Inc.
Issuer
Opiant Pharmaceuticals, Inc.